The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,271,750 in first-year total cost, median $465,750.
Most frequent study sections
- Special Emphasis Panel[ZDA1 MXS-N (J1)]3
- Special Emphasis Panel[ZDA1 MXS-M (M1)]2
Most frequent institutions
- BAYLOR COLLEGE OF MEDICINE1
- OREGON HEALTH & SCIENCE UNIVERSITY1
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH1
- VANDERBILT UNIVERSITY1
- VIRGINIA COMMONWEALTH UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Developing Tools to Facilitate Dynamics-Based Drug Discovery of Receptors of Drugs of Abuse1DP1DA063082-01 | ROBERTSON, MICHAEL | BAYLOR COLLEGE OF MEDICINE, TX | $480,000 | ZDA1 |
| 2025 | A Highly Precise Platform Technology for Controlling Diverse Clinical Targets in Addiction1DP1DA063097-01 | DONTHAMSETTI, PRASHANT CHANDRA | VANDERBILT UNIVERSITY, TN | $475,500 | ZDA1 |
| 2025 | Novel Mu Opioid Receptor Modulators to Counteract Synthetic Opioids1DP1DA063098-01 | PAGARE, PIYUSHA P | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $465,750 | ZDA1 |
| 2024 | DEVELOPING GPCR MODULATORS OF SOMATOSTATIN INTERNEURONS FOR THE TREATMENT OF OPIOID USE DISORDER1DP1DA060482-01 | JOFFE, MAX E | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $429,300 | ZDA1 |
| 2024 | Chemical biology tools for illuminating cannabinoid signaling pathways in opioid use disorder.1DP1DA060496-01 | FRANK, JAMES ALLEN | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $421,200 | ZDA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.